Medicine to treat asthma could help reduce ‘life-threatening reactions’ to food allergies - study
Researchers have found that Omalizumab, a drug commonly prescribed to treat asthma, could also limit “life-threatening reactions” to food allergies in children. Omalizumab, known under the brand name Xolair, is a medication approved to treat severe persistent asthma caused by an allergy. “The day-to-day life of patients with food allergy is consumed by fear of accidental exposure to food allergens,” Dr Robert Wood, professor of paediatrics at the Johns Hopkins University and the study’s main author, said in a statement. “Our findings have the potential to be very meaningful, and potentially ev...